# Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial

> **NCT06669130** · NA · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Rhinosinusitis (CRS)

## Interventions

- **DEVICE:** Xiangtong TM full degradation sinus drug stent system
- **DEVICE:** nasopore

## Key facts

- **NCT ID:** NCT06669130
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06669130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06669130, "Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06669130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*